| IQGAP1 suppresses TβRII-mediated myofibroblastic activation and metastatic growth in liver C Liu, DD Billadeau, H Abdelhakim, E Leof, K Kaibuchi, C Bernabeu, ... The Journal of clinical investigation 123 (3), 1138-1156, 2013 | 102 | 2013 |
| WJMSC‐derived small extracellular vesicle enhance T cell suppression through PD‐L1 M Li, R Soder, S Abhyankar, H Abdelhakim, MW Braun, CV Trinidad, ... Journal of extracellular vesicles 10 (4), e12067, 2021 | 52 | 2021 |
| Impact of SARS-CoV-2 in hematopoietic stem cell transplantation and chimeric antigen receptor T cell therapy recipients MU Mushtaq, M Shahzad, SG Chaudhary, M Luder, N Ahmed, ... Transplantation and cellular therapy 27 (9), 796. e1-796. e7, 2021 | 49 | 2021 |
| Role of αβ T cell depletion in prevention of graft versus host disease H Abdelhakim, H Abdel-Azim, A Saad Biomedicines 5 (3), 35, 2017 | 44 | 2017 |
| A phase I study to evaluate two doses of Wharton’s jelly-derived mesenchymal stromal cells for the treatment of de novo high-risk or steroid-refractory acute graft versus host … RP Soder, B Dawn, ML Weiss, N Dunavin, S Weir, J Mitchell, M Li, ... Stem cell reviews and reports 16, 979-991, 2020 | 35 | 2020 |
| Outcomes with allogeneic hematopoietic stem cell transplantation in TP53-mutated acute myeloid leukemia: a systematic review and meta-analysis M Shahzad, E Tariq, SG Chaudhary, I Anwar, Q Iqbal, H Fatima, ... Leukemia & Lymphoma 63 (14), 3409-3417, 2022 | 13 | 2022 |
| Results of the first clinical study in humans that combines hyperbaric oxygen pretreatment with autologous peripheral blood stem cell transplantation H Abdelhakim, L Shune, S Bhatti, AR Cantilena, A Baran, TL Lin, ... Biology of Blood and Marrow Transplantation 25 (9), 1713-1719, 2019 | 8 | 2019 |
| Long-term results of a pilot study evaluating hyperbaric oxygen therapy to improve umbilical cord blood engraftment A Mina, L Shune, H Abdelhakim, TL Lin, S Ganguly, A Baran, A Singh, ... Annals of Hematology 98, 481-489, 2019 | 7 | 2019 |
| LAG3 inhibition decreases AML-induced immunosuppression and improves T cell-mediated killing H Abdelhakim, LM Cortez, M Li, M Braun, BS Skikne, TL Lin, N Dunavin, ... Blood 134, 3605, 2019 | 5 | 2019 |
| “Waitlist mortality” is high for myeloma patients with limited access to BCMA therapy N Ahmed, W Wesson, MU Mushtaq, R Bansal, H AbdelHakim, S Bromert, ... Frontiers in Oncology 13, 1206715, 2023 | 4 | 2023 |
| Morphologic, immunophenotypic, and molecular genetic comparison study in patients with clonal cytopenia of undetermined significance, myelodysplastic syndrome, and acute … L Gao, S Hyter, D Zhang, S Kelting, J Woodroof, AO Abdallah, A Yacoub, ... International journal of laboratory hematology 44 (4), 738-749, 2022 | 4 | 2022 |
| Non-relapse mortality in TP53-mutated MDS/AML-a multi-center collaborative study MT Byrne, TJ Kurian, DA Patel, R Tamari, S Hong, H Abdelhakim, V Klein, ... Blood 138, 2922, 2021 | 4 | 2021 |
| Peri-transplant extracorporeal photopheresis to mitigate GVHD-a pilot clinical trial H Abdelhakim, A Accurso, D Merkel, S Dejarnette, O Aljitawi, T Yankee, ... Bone Marrow Transplantation 56 (4), 980-982, 2021 | 4 | 2021 |
| Outcomes of autologous hematopoietic cell transplantation patients receiving hyperbaric oxygen therapy H Abdelhakim, S Bhatti, AR Cantilena, TL Lin, S Ganguly, AK Singh, ... Biology of Blood and Marrow Transplantation 23 (3), S131-S132, 2017 | 3 | 2017 |
| Outcomes with HLA-matched unrelated donor versus haploidentical hematopoietic cell transplantation MU Mushtaq, M Shahzad, MK Amin, F Lutfi, S DeJarnette, JS Al-Ramahi, ... Leukemia & Lymphoma 65 (4), 493-502, 2024 | 2 | 2024 |
| Use of endpoints in phase III randomized controlled trials for acute myeloid leukemia over the last 15 years: a systematic review M Shahzad, SG Chaudhary, E Tariq, AH Mushtaq, I Anwar, N Ahmed, ... Leukemia & Lymphoma 64 (2), 273-282, 2023 | 2 | 2023 |
| Telehealth to increase access to transplant survivorship care for allogeneic stem cell transplant recipients regardless of distance to transplant center or neighborhood income. N Ahmed, S Fitzmaurice, C Morey, T Torres, D Beckman, S Ganguly, ... Journal of Clinical Oncology 39 (15_suppl), e13615-e13615, 2021 | 2 | 2021 |
| Outcomes of HMA and Venetoclax in Relapsed AML Post-Allogenic hematopoietic stem cell transplant O Diab, H Abdelhakim, JP McGuirk, T Lin Blood 136, 33-34, 2020 | 2 | 2020 |
| Adherent cell depletion promotes the expansion of renal cell carcinoma infiltrating T cells with optimal characteristics for adoptive transfer MW Braun, H Abdelhakim, M Li, S Hyter, Z Pessetto, DC Koestler, ... Journal for Immunotherapy of Cancer 8 (2), 2020 | 2 | 2020 |
| Favorable outcomes following CD34-selected stem cell boost for poor graft function after allogeneic hematopoietic stem cell transplantation JS Al-Ramahi, M Shahzad, A Nguyen, K Li, MK Amin, N Ahmed, F Lutfi, ... Bone Marrow Transplantation 59 (1), 134-137, 2024 | 1 | 2024 |
Neil DunavinUniversity of California San Francisco在 ucsf.edu 的电子邮件经过验证
